Search Results - "Stroncek, D."

Refine Results
  1. 1

    Human natural killer cell manufacturing using a closed system process for patients with metastatic solid tumors or hematologic malignancies by Jin, J, Reger, R, Panch, S, Childs, R, Stroncek, D, Highfill, S.L

    Published in Cytotherapy (Oxford, England) (01-05-2019)
    “…Background & AimAs potent effectors of the innate immune system natural killer (NK) cells are currently utilized in clinical trials world-wide to treat a…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort by Heim, K.F., Fleisher, T.A., Stroncek, D.F., Holland, S.M., Gallin, J.I., Malech, H.L., Leitman, S.F.

    Published in Transfusion (Philadelphia, Pa.) (01-06-2011)
    “…BACKGROUND: The efficacy of granulocyte transfusions in patients with HLA alloimmunization is uncertain. A flow cytometric assay using dihydrorhodamine 123…”
    Get full text
    Journal Article
  5. 5

    immunologic aspects of poxvirus oncolytic therapy by Worschech, Andrea, Haddad, D, Stroncek, D. F, Wang, E, Marincola, Francesco M, Szalay, Aladar A

    Published in Cancer Immunology, Immunotherapy (01-09-2009)
    “…The concept of using replicating oncolytic viruses in cancer therapy dates to the beginning of the twentieth century. However, in the last few years, an…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers by Stroncek, John D, Grant, Bryan S, Brown, Melissa A, Povsic, Thomas J, Truskey, George A, Reichert, William M

    Published in Tissue engineering. Part A (01-11-2009)
    “…The lack of easily isolated autologous endothelial cell (EC) sources is one of the major challenges with vascular tissue engineering interventions. This…”
    Get more information
    Journal Article
  11. 11

    Instructional PowerPoint presentations for cutaneous wound healing and tissue response to sutures by Stroncek, John D., Bell, Nicole, Reichert, W. Monty

    “…Wound healing is an intricate process involving the interaction of cells and molecules, resulting in a complex series of events that change the morphology and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin by Stroncek, John D, Xue, Yujing, Haque, Nabila, Lawson, Jeffrey H, Reichert, William M

    Published in Tissue engineering. Part A (01-08-2011)
    “…This study investigated the augmentation of endothelial progenitor cell (EPC) thromboresistance by using gene therapy to overexpress thrombomodulin (TM), an…”
    Get more information
    Journal Article
  14. 14

    The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study by Silliman, Christopher C., Paterson, Andrew J., Dickey, William O., Stroncek, David F., Popovsky, Mark A., Caldwell, Sherrie A., Ambruso, Daniel R.

    Published in Transfusion (Philadelphia, Pa.) (01-07-1997)
    “…BACKGROUND: Transfusion‐related acute lung injury (TRALI) is clinically similar to the adult respiratory distress syndrome (ARDS) and has been linked to the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model by Stroncek, J.D., Ren, L.C., Klitzman, B., Reichert, W.M.

    Published in Acta biomaterialia (01-01-2012)
    “…Late outgrowth endothelial progenitor cells (EPCs) derived from the peripheral blood of patients with significant coronary artery disease were sodded into the…”
    Get full text
    Journal Article
  17. 17

    Patient‐specific transfusion‐related acute lung injury by Muniz, M., Sheldon, S., Schuller, R. M., Young, N. S., Klein, H. G., Leitman, S. F., Stroncek, D. F.

    Published in Vox sanguinis (01-01-2008)
    “…Transfusion‐related acute lung injury (TRALI) is one of the leading causes of transfusion‐associated mortality. The inadvertent transfusion of neutrophil…”
    Get full text
    Journal Article
  18. 18

    Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells by Stroncek, D F, Clay, M E, Petzoldt, M L, Smith, J, Jaszcz, W, Oldham, F B, McCullough, J

    Published in Transfusion (Philadelphia, Pa.) (01-07-1996)
    “…Granulocyte-colony-stimulating factor (G-CSF) has been used in patients to increase the level of circulating hematopoietic progenitors. Although G-CSF has been…”
    Get more information
    Journal Article
  19. 19

    Venous injection of a triphasic calcium-based implant in a sheep model of pulmonary embolism demonstrates minimal acute systemic effects by Constant, Caroline, Stroncek, John D., Zeiter, Stephan, Arens, Daniel, Nehrbass, Dirk, Gehweiler, Dominic, Menzel, Ursula, Benneker, Lorin M., Hill, Ronald S., Albers, Christoph E.

    Published in European spine journal (01-10-2022)
    “…Purpose Implant leakage is the most common complication of vertebral augmentation. Alternative injectable materials must demonstrate intravascular safety…”
    Get full text
    Journal Article
  20. 20

    In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium‐based implant confers immediate biomechanical integrity by Stroncek, John D., Shaul, Jonathan L., Favell, Dominique, Hill, Ronald S., Huber, Bryan M., Howe, James G., Bouxsein, Mary L.

    Published in Journal of orthopaedic research (01-04-2019)
    “…ABSTRACT Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to…”
    Get full text
    Journal Article